Precept Management’s CareDx CDNA Stock Holding History

Precept Management’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-50,000	Closed	-$1.44M	–	47
2018 Q3	$1.44M	Buy	+50,000	New	+$936K	0.41%	50

Other funds holding CDNA

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

ICM

ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Precept Management's CDNA Position: Q4 2018 in Review

Precept Management sold out of CareDx (CDNA) in Q4 2018, closing a stake of 50,000 shares — an estimated $1.44M sold.

Precept Management first reported a position in CDNA in Q3 2018 and held it in 1 quarter. The position peaked at $1.44M in Q3 2018. 148 funds tracked by Wall St. Rank hold CDNA as of Q4 2018.

Precept Management reported no remaining CareDx position as of Q4 2018 after selling out during the quarter.
Precept Management sold 50,000 CareDx shares in Q4 2018, an estimated $1.44M.
Precept Management first reported a position in CareDx in Q3 2018 and held it in 1 quarter.
Precept Management's CareDx position peaked at $1.44M in Q3 2018.
148 funds tracked by Wall St. Rank held CareDx as of Q4 2018.

Based on Precept Management's 13F filing for Q4 2018, filed 14 Feb 2019.